View Older Stories View More Recent Stories

Dec 1, 2022 08:00AM Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
Nov 30, 2022 04:12PM Aziyo Biologics (AZYO) Announces Proposed Public Offering of Common Stock
Nov 30, 2022 04:08PM Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
Nov 30, 2022 06:34AM Cantor Fitzgerald Upgrades SoundHound AI Inc. (SOUN) to Overweight
Nov 29, 2022 03:30PM EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts
Nov 29, 2022 03:30PM EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts
Nov 29, 2022 03:24PM EF Hutton Expands Healthcare Franchise with Appointments of Veteran Equity Research Analysts 
Nov 29, 2022 09:03AM Alaunos Therapeutics (TCRT) Prices Public Offering of Common Stock for Gross Proceeds of Approximately $15.7 Million
Nov 29, 2022 09:01AM Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock
Nov 29, 2022 08:00AM Lineage to Present at BTIG Ophthalmology Day and the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Nov 28, 2022 04:01PM Alaunos Therapeutics (TCRT) Announces Proposed Public Offering of Common Stock
Nov 28, 2022 04:01PM Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
Nov 28, 2022 09:28AM Form NPORT-P CANTOR FITZGERALD SUSTAI For: Sep 30
Nov 22, 2022 04:21PM Form APP NTC CANTOR FITZGERALD SUSTAI
Nov 22, 2022 01:33PM Cantor Fitzgerald Downgrades Opiant Pharma (OPNT) to Neutral on Acqusition
Nov 22, 2022 12:53PM Redhill Biopharma (RDHL) PT Lowered to $1 at Cantor Fitzgerald
Nov 22, 2022 08:00AM Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Nov 22, 2022 08:00AM Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Nov 22, 2022 08:00AM OcuTerra to Participate in Upcoming Investor Conferences
Nov 21, 2022 04:05PM Aziyo Biologics to Participate in Upcoming Investor Conferences
Nov 18, 2022 05:02PM Form 8-K Cantor Fitzgerald Income For: Nov 16
Nov 18, 2022 01:52PM Form N-23C3A CANTOR FITZGERALD SUSTAI For: Nov 18
Nov 18, 2022 06:44AM Companies with NDRs 11/18
Nov 18, 2022 06:03AM Cantor Fitzgerald Starts Precigen Inc. (PGEN) at Overweight, PT $7
Nov 18, 2022 05:12AM RAPT Therapeutics (RAPT) Prices 4.05M Share Offering at $18.50/sh
Nov 17, 2022 09:38PM RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
Nov 17, 2022 09:38PM RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
Nov 17, 2022 05:54PM Today's most important initiations
Nov 17, 2022 04:25PM RAPT Therapeutics (RAPT) Announces Proposed $75M Stock Offering
Nov 17, 2022 04:24PM RAPT Therapeutics Announces Proposed Public Offering of Common Stock
Nov 17, 2022 04:24PM RAPT Therapeutics Announces Proposed Public Offering of Common Stock
Nov 17, 2022 07:43AM Companies with NDRs 11/17
Nov 17, 2022 06:55AM Ardelyx (ARDX) Kept at Neutral by Cantor Fitzgerald, "Need More Commercial Visibility"
Nov 17, 2022 06:21AM Cantor Fitzgerald Starts Kempharm (KMPH) at Overweight
Nov 17, 2022 06:20AM Cantor Fitzgerald Starts Theratechnologies Inc. (THTX) at Overweight
Nov 16, 2022 05:12PM Form 424B3 Cantor Fitzgerald Income
Nov 16, 2022 02:10PM Form SC 13G UTA Acquisition Corp Filed by: CANTOR FITZGERALD SECURITIES
Nov 16, 2022 08:40AM Form SC 13D/A BGC Partners, Inc. Filed by: CANTOR FITZGERALD, L. P.
Nov 16, 2022 08:02AM BGC Partners (BGCP) Announces Corporate Conversion Agreement, New Company Name "BGC Group" And New Ticker Symbol "BGC" In Connection With Its Conversion Into a Corporate Structure
Nov 16, 2022 08:00AM BGC Partners Announces Corporate Conversion Agreement, New Company Name "BGC Group" And New Ticker Symbol "BGC" In Connection With Its Conversion Into a Corporate Structure
Nov 16, 2022 07:04AM Companies with NDRs 11/16
Nov 16, 2022 06:34AM UPDATE: Cantor Fitzgerald Downgrades NexImmune Inc (NEXI) to Neutral
Nov 15, 2022 04:20PM PAVmed Provides Business Update and Third Quarter 2022 Financial Results
Nov 15, 2022 12:55PM Cognition Therapeutics Announces Closing of Public Offering
Nov 15, 2022 12:55PM Electra Closes US$5.5 Million Public Equity Offering
Nov 15, 2022 12:55PM Cognition Therapeutics Announces Closing of Public Offering
Nov 14, 2022 04:40PM Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
Nov 14, 2022 04:01PM Form 13F-NT Cantor Fitzgerald Europe For: Sep 30
Nov 14, 2022 04:00PM Form 13F-NT CANTOR FITZGERALD & CO. For: Sep 30
Nov 14, 2022 03:59PM Form 13F-NT CANTOR FITZGERALD INVEST For: Sep 30
View More Recent Stories View Older Stories